Teva Pharmaceutical Industries Limited (TEVA) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Teva Pharmaceutical Industries Limited (TEVA) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

TEVA Cash Flow Statement

Teva Pharmaceutical Industries Limited (TEVA) cash flow statement — 30-year operating, investing & financing cash flows

Annual Quarterly

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Cash from Operations	241M	411M	-40M	1.16B	369M	227M	-105M	575M	693M	103M	-124M	1.18B	5M	324M	-145M	973M	543M	123M	-49M	456M
Operating CF Margin %	5.48%	9.92%	-1%	24.58%	8.24%	5.44%	-2.7%	13.6%	16%	2.47%	-3.25%	26.57%	0.13%	8.35%	-3.96%	25.06%	15.1%	3.25%	-1.34%	11.12%
Operating CF Growth %	-34.69%	81.06%	61.9%	101.39%	-46.75%	120.39%	15.32%	-51.44%	13760%	-68.21%	14.48%	21.69%	-99.08%	163.41%	-195.92%	113.38%	2.65%	-43.58%	87.9%	37.76%
Net Income	234M	-575M	369M	481M	434M	283M	220M	-275M	-390M	-874M	-419M	433M	88M	-898M	-238M	-1.25B	58M	-259M	-952M	-152M
Depreciation & Amortization	245M	241M	239M	260M	249M	251M	244M	269M	259M	259M	272M	266M	283M	300M	304M	306M	321M	358M	323M	320M
Stock-Based Compensation	38M	40M	43M	51M	34M	38M	34M	34M	29M	32M	28M	28M	31M	30M	32M	36M	26M	39M	24M	33M
Deferred Taxes	0	25M	-22M	-595M	107M	-211M	28M	32M	-53M	-424M	-189M	32M	-199M	-44M	-106M	155M	44M	-1.08B	-175M	-133M
Other Non-Cash Items	-603M	844M	-52M	732M	106M	202M	69M	760M	531M	1.12B	681M	99M	40M	732M	227M	1.48B	1M	714M	172M	208M
Working Capital Changes	327M	-164M	-617M	229M	-561M	-336M	-700M	-245M	317M	-10M	-497M	326M	-238M	204M	-364M	250M	93M	354M	559M	180M
Change in Receivables	327M	0	0	0	0	0	0	0	0	0	0	0	362M	371M	323M	591M	0	0	305M	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-163M	0	0	0	0
Change in Payables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	163M	0	0	0	0
Cash from Investing	210M	-491M	229M	165M	135M	236M	201M	202M	268M	178M	144M	301M	184M	302M	181M	170M	147M	179M	161M	246M
Capital Expenditures	-120M	-104M	-168M	-142M	-136M	-96M	-127M	-129M	-148M	-97M	-124M	-119M	-149M	-119M	-139M	-142M	-122M	-127M	-157M	-153M
CapEx % of Revenue	2.73%	2.51%	4.22%	3.01%	3.04%	2.3%	3.26%	3.05%	3.42%	2.33%	3.25%	2.67%	3.87%	3.07%	3.8%	3.66%	3.39%	3.35%	4.29%	3.73%
Acquisitions	0	-692M	42M	0	8M	9M	17M	4M	38M	1M	-15M	0	10M	56M	2M	23M	2M	18M	-7M	42M
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	330M	306M	355M	282M	276M	339M	322M	342M	339M	317M	295M	422M	371M	-4M	322M	286M	263M	285M	329M	357M
Cash from Financing	6M	-1M	13M	40M	-453M	6M	-1.74B	-674M	0	-966M	-151M	-576M	-576M	-55M	-706M	-713M	-439M	-338M	2M	-501M
Debt Issued (Net)	-37.39M	0	-23M	-1.36M	-451M	5M	-1.37B	-685M	0	-956M	0	-500M	-500M	0	-701M	-708M	-365M	-296M	0	-500M
Equity Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	43.39M	-1M	36M	41.36M	-2M	1M	-376M	11M	0	-10M	-151M	-76M	-76M	-55M	-5M	-3M	-74M	-42M	2M	-1M
Net Change in Cash	430M	-86M	185M	1.35B	42M	464M	-1.6B	-19M	1.06B	-733M	-236M	977M	-420M	494M	-658M	576M	167M	-159M	52M	153M
Free Cash Flow	121M	307M	-208M	1.02B	233M	131M	-232M	446M	545M	6M	-248M	1.06B	-144M	205M	-284M	831M	421M	-4M	-206M	303M
FCF Margin %	2.75%	7.41%	-5.22%	21.57%	5.2%	3.14%	-5.96%	10.55%	12.58%	0.14%	-6.49%	23.89%	-3.74%	5.29%	-7.76%	21.4%	11.71%	-0.11%	-5.63%	7.39%
FCF Growth %	-48.07%	134.35%	10.34%	127.8%	-57.25%	2083.33%	6.45%	-58.12%	478.47%	-97.07%	12.68%	28.16%	-134.2%	5225%	-37.86%	174.26%	9.92%	-103.81%	62.88%	95.48%
FCF per Share	0.10	0.26	-0.18	0.87	0.20	0.11	-0.20	0.39	0.48	0.01	-0.22	0.94	-0.13	0.18	-0.25	0.75	0.38	-0.00	-0.19	0.27
FCF Conversion (FCF/Net Income)	1.03x	-0.71x	-0.11x	2.41x	0.85x	0.80x	-0.49x	-2.65x	-1.59x	-0.12x	0.89x	2.56x	0.07x	-0.37x	0.66x	-0.80x	9.70x	-0.53x	0.05x	-2.87x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0